| Literature DB >> 32320658 |
Teun M Klein Gunnewiek1, Eline J H Van Hugte2, Monica Frega3, Gemma Solé Guardia1, Katharina Foreman4, Daan Panneman5, Britt Mossink2, Katrin Linda2, Jason M Keller2, Dirk Schubert4, David Cassiman6, Richard Rodenburg7, Noemi Vidal Folch5, Devin Oglesbee5, Ester Perales-Clemente5, Timothy J Nelson8, Eva Morava9, Nael Nadif Kasri10, Tamas Kozicz11.
Abstract
Epilepsy, intellectual and cortical sensory deficits, and psychiatric manifestations are the most frequent manifestations of mitochondrial diseases. How mitochondrial dysfunction affects neural structure and function remains elusive, mostly because of a lack of proper in vitro neuronal model systems with mitochondrial dysfunction. Leveraging induced pluripotent stem cell technology, we differentiated excitatory cortical neurons (iNeurons) with normal (low heteroplasmy) and impaired (high heteroplasmy) mitochondrial function on an isogenic nuclear DNA background from patients with the common pathogenic m.3243A > G variant of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). iNeurons with high heteroplasmy exhibited mitochondrial dysfunction, delayed neural maturation, reduced dendritic complexity, and fewer excitatory synapses. Micro-electrode array recordings of neuronal networks displayed reduced network activity and decreased synchronous network bursting. Impaired neuronal energy metabolism and compromised structural and functional integrity of neurons and neural networks could be the primary drivers of increased susceptibility to neuropsychiatric manifestations of mitochondrial disease.Entities:
Keywords: MELAS; induced pluripotent stem cells; m.3243A > G; micro-electrode array; mitochondria; mitochondrial disease; network activity; neurodevelopment; neuron
Mesh:
Year: 2020 PMID: 32320658 DOI: 10.1016/j.celrep.2020.107538
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423